Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	LC350189 50mg	34
Overall Study	STARTED	LC350189 100mg	38
Overall Study	STARTED	LC350189 200mg	37
Overall Study	STARTED	Placebo	34
Overall Study	COMPLETED	LC350189 50mg	30
Overall Study	COMPLETED	LC350189 100mg	32
Overall Study	COMPLETED	LC350189 200mg	34
Overall Study	COMPLETED	Placebo	32
Overall Study	NOT COMPLETED	LC350189 50mg	4
Overall Study	NOT COMPLETED	LC350189 100mg	6
Overall Study	NOT COMPLETED	LC350189 200mg	3
Overall Study	NOT COMPLETED	Placebo	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03934099/flow